Inogen shares plummeted 22 percent Jan. 13 with the release of preliminary full-year financial results that fell short of prior estimates by the firm. The Goleta oxygen concentrator maker said it expects full-year revenue between $361.4 million and $362.4 million, below previous guidance in the range of $370 million to $375 million. Shares fell $13.48…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
